Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHEMORESISTANCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 161 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baltaci, S; Orhan, D; Turkolmez, K; Yesilli, C; Beduk, Y; Tulunay, O
      P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours

      BJU INTERNATIONAL
    2. Augusseau-Caillot, A; Soler, C; Teyssier, F; Perrot, JL; Tiffet, O; Cambazard, F; Cuilleret, J; Dumollard, JM
      Interest of PS100 assay when Tc-99m sestamibi scintigraphy failed to identify lymph node metastases of melanoma

      EUROPEAN JOURNAL OF DERMATOLOGY
    3. Gravis, G; Mousseau, M; Douillard, JY; Dorval, T; Fabbro, M; Escudier, B; Mignot, L; Viens, P
      Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial

      EUROPEAN CYTOKINE NETWORK
    4. Schmitt, CA; Lowe, SW
      Bcl-2 mediates chemoresistance in matched pairs of primary E mu-myc lymphomas in vivo

      BLOOD CELLS MOLECULES AND DISEASES
    5. Weinstein-Oppenheimer, CR; Henriquez-Roldan, CF; Davis, JM; Navolanic, PM; Saleh, OA; Steelman, LS; Franklin, RA; Robinson, PJ; McMahon, M; McCubrey, JA
      Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin

      CLINICAL CANCER RESEARCH
    6. Brabender, J; Danenberg, KD; Metzger, R; Schneider, PM; Park, JM; Salonga, D; Holscher, AH; Danenberg, PV
      Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival

      CLINICAL CANCER RESEARCH
    7. O'Toole, SA; Sheppard, BL; McGuinness, E; Gleeson, NC; Bonnar, J
      Serous papillary adenocarcinomas of the ovary display heterogeneity in their response to chemotherapy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    8. Luo, Y; Prestwich, GD
      Hyaluronic acid-N-hydroxysuccinimide: A useful intermediate for bioconjugation

      BIOCONJUGATE CHEMISTRY
    9. Pepper, C; Hooper, K; Thomas, A; Hoy, T; Bentley, P
      Bcl-2 antisense oligonucleotides enhance the cytotoxicity of Chlorambucil in B-cell chronic lymphocytic leukaemia cells

      LEUKEMIA & LYMPHOMA
    10. Rosell, R; Taron, M; O'Brate, A
      Predictive molecular markers in non-small cell lung cancer

      CURRENT OPINION IN ONCOLOGY
    11. Higashiyama, M; Kodama, K; Yokouchi, H; Takami, K; Nakagawa, H; Imamura, F; Minamigawa, K; Kobayashi, H
      Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: Relation of the in vitro chemosensitive test to clinical response

      ONCOLOGY REPORTS
    12. Shah, SA; Potter, MW; Callery, MP
      Ubiquitin proteasome pathway: implications and advances in cancer therapy

      SURGICAL ONCOLOGY-OXFORD
    13. Um, JH; Kang, CD; Lee, BG; Kim, DW; Chung, BS; Kim, SH
      Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance

      ONCOGENE
    14. Shah, N; Thomas, TJ; Lewis, JS; Klinge, CM; Shirahata, A; Gelinas, C; Thomas, T
      Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells

      ONCOGENE
    15. Wacheck, V; Heere-Ress, E; Halaschek-Wiener, J; Lucas, T; Meyer, H; Eichler, HG; Jansen, B
      Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model

      JOURNAL OF MOLECULAR MEDICINE-JMM
    16. Campone, M; Vavasseur, F; Le Cabellec, MT; Meflah, K; Vallette, FM; Oliver, L
      Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein

      LEUKEMIA
    17. Siegmund, B; Welsch, J; Loher, F; Meinhardt, G; Emmerich, B; Endres, S; Eigler, A
      Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptoticmembers of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis

      LEUKEMIA
    18. O'Gorman, DM; Cotter, TG
      Molecular signals in anti-apoptotic survival pathways

      LEUKEMIA
    19. Shah, SA; Potter, MW; McDade, TP; Ricciardi, R; Perugini, RA; Elliott, PJ; Adams, J; Callery, MP
      26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

      JOURNAL OF CELLULAR BIOCHEMISTRY
    20. Ling, YH; Donato, NJ; Perez-Soler, R
      Sensitivity to topoisomerase I inhibitors and cisplatin is associated withepidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Tamatani, T; Azuma, M; Aota, K; Yamashita, T; Bando, T; Sato, M
      Enhanced I kappa B kinase activity is responsible for the augmented activity of NF-kappa B in human head and neck carcinoma cells

      CANCER LETTERS
    22. Makin, GWJ; Corfe, BM; Griffiths, GJ; Thistlethwaite, A; Hickman, JA; Dive, C
      Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate

      EMBO JOURNAL
    23. Kawakami, Y; Hama, S; Hiura, M; Nogawa, T; Chiba, T; Yokoyama, T; Takashima, S; Tajiri, H; Eguchi, K; Nagai, N; Shigemasa, K; Ohama, K; Kurisu, K; Heike, Y
      Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells

      ANTICANCER RESEARCH
    24. Agiostratidou, G; Sgouros, I; Galani, E; Voulgari, A; Chondrogianni, N; Samantas, E; Dimopoulos, MA; Skarlos, D; Gonos, ES
      Correlation of in vitro cytotoxicity and clinical response to chemotherapyin ovarian and breast cancer patients

      ANTICANCER RESEARCH
    25. Olson, DP; Taylor, BJ; Ivy, SP
      Detection of MRP functional activity: Calcein AM but not BCECF AM as a multidrug resistance-related protein (MRP1) substrate

      CYTOMETRY
    26. Sinha, P; Poland, J; Schnolzer, M; Celis, JE; Lage, H
      Characterization of the differential protein expression associated with thermoresistance in human gastric carcinoma cell lines

      ELECTROPHORESIS
    27. Paik, S; Park, C
      HER-2 and choice of adjuvant chemotherapy in breast cancer

      SEMINARS IN ONCOLOGY
    28. Goff, BA; Paley, PJ; Greer, BE; Gown, AM
      Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    29. Soengas, MS; Capodieci, P; Polsky, D; Mora, J; Esteller, M; Opitz-Araya, X; McCombie, R; Herman, JG; Gerald, WL; Lazebnik, YA; Cordon-Cardo, C; Lowe, SW
      Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

      NATURE
    30. Matheson, SL; McNamee, J; Jean-Claude, BJ
      Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: A novel tumor targeting strategy

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    31. Chaudhary, KS; Abel, PD; Stamp, GWH; Lalani, EN
      Differential expression of cell death regulators in response to thapsigargin and adriamycin in Bcl-2 transfected DU145 prostatic cancer cells

      JOURNAL OF PATHOLOGY
    32. Hengstler, JG; Pilch, H; Schmidt, M; Dahlenburg, H; Sagemuller, J; Schiffer, I; Oesch, F; Knapstein, PG; Kaina, B; Tanner, B
      Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

      INTERNATIONAL JOURNAL OF CANCER
    33. Weber, RG; Rieger, J; Naumann, U; Lichter, P; Weller, M
      Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma eel lines

      INTERNATIONAL JOURNAL OF CANCER
    34. Cusack, JC; Liu, R; Houston, M; Abendroth, K; Elliott, PJ; Adams, J; Baldwin, AS
      Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: Implications for systemic nuclear factor-kappa B inhibition

      CANCER RESEARCH
    35. Bergmann, M; Romirer, I; Sachet, M; Fleischhacker, R; Garcia-Sastre, A; Palese, P; Wolff, K; Pehamberger, H; Jakesz, R; Muster, T
      A genetically engineered influenza A virus with ras-dependent oncolytic properties

      CANCER RESEARCH
    36. Pepper, C; Thomas, A; Hoy, T; Fegan, C; Bentley, P
      Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis anddrug resistance in B-cell chronic lymphocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    37. Fennell, DA; Corbo, MV; Dean, NM; Monia, BP; Cotter, FE
      In vivo suppression of Bcl-X-L expression facilitates chemotherapy-inducedleukaemia cell death in a SCID/NOD-Hu model

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Chen, F; Castranova, V; Shi, XL
      New insights into the role of nuclear factor-kappa B in cell growth regulation

      AMERICAN JOURNAL OF PATHOLOGY
    39. Jarvinen, TAH; Liu, ET
      Effects of HER-2/neu on chemosensitivity of tumor cells

      DRUG RESISTANCE UPDATES
    40. Huang, ZW
      Bcl-2 family proteins as targets for anticancer drug design

      ONCOGENE
    41. Cheng, QW; Lee, HH; Li, Y; Parks, TP; Cheng, GH
      Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappa B inhibition

      ONCOGENE
    42. Schmidt, M; Lu, Y; Liu, BL; Fang, M; Mendelsohn, J; Fan, Z
      Differential modulation of paclitaxel-mediated apoptosis by p21(Waf1) and p27(Kip1)

      ONCOGENE
    43. Tsai, CM; Chang, KT; Li, L; Perng, RP; Yang, LY
      Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    44. Luo, D; Cheng, SCS; Xie, H; Xie, Y
      Effects of Bcl-2 and Bcl-X-L protein levels on chemoresistance of hepatoblastoma HepG2 cell line

      BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
    45. Fortin, A; Raybaud-Diogene, H; Tetu, B; Huot, J; Landry, J; Deschenes, R
      Overexpression of the 27 kDa heat shock protein is associated with thermoresistance and chemoresistance but not with radioresistance

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    46. Witkowski, JM; Kozlowska, K; Zarzeczna, M
      Expression and activity of P-glycoprotein in transplantable hamster melanomas

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    47. Lincet, H; Poulain, L; Remy, JS; Deslandes, E; Duigou, F; Gauduchon, P; Staedel, C
      The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells

      CANCER LETTERS
    48. Wu, JH; Batist, G; Zamir, LO
      A model for the interaction of paclitaxel with the Bcl-2 loop domain: a chemical approach to induce conformation-dependent phosphorylation

      ANTI-CANCER DRUG DESIGN
    49. Agiostratidou, G; Demertzis, N; Gonos, ES
      Evaluation of cytotoxic treatment of patients with osteosarcoma by an in vitro chemoresistance assay

      ANTICANCER RESEARCH
    50. Dimanche-Boitrel, MT; Micheau, O; France, D; Hammann, A; Duchamp, O; Genne, P; Solary, E
      P27(KiP1) overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo

      ANTICANCER RESEARCH
    51. Boutonnat, J; Barbier, M; Muirhead, K; Mousseau, M; Grunwald, D; Ronot, X; Seigneurin, D
      Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: Simultaneous assessment of proliferation, apoptosis, and necrosis

      CYTOMETRY
    52. Sinha, P; Kohl, S; Fischer, J; Hutter, G; Kern, M; Kottgen, E; Dietel, M; Lage, H; Schnolzer, M; Schadendorf, D
      Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis

      ELECTROPHORESIS
    53. Mottolese, M; Benevolo, M; Del Monte, G; Buglioni, S; Papaldo, P; Nistico, C; Di Filippo, F; Vasselli, S; Vici, P; Botti, C
      Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    54. Fernandez, PM; Tabbara, SO; Jacobs, LK; Manning, FCR; Tsangaris, TN; Schwartz, AM; Kennedy, KA; Patierno, SR
      Overexpression of the glucose-regulated stress gene GRP78 in malignant butnot benign human breast lesions

      BREAST CANCER RESEARCH AND TREATMENT
    55. Carrington, D; Algar, E
      Overexpression of murine WT1+/+ and -/- isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line

      LEUKEMIA RESEARCH
    56. Adou-Bryn, KD; Kouassi, D; Ouhon, J; Assoumou, A; Kone, M
      Clinical trial of amodiaquine in Attecoube (Abidjan, Cote d'Ivoire) (May-December 1995)

      BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
    57. Chuang, CK; Shen, YC; Wu, JH; Tsai, LH; Liao, SK
      Immunobiologic, cytogenetic and drug response features of a newly established cell line (SCRC-1) from renal small cell carcinoma

      JOURNAL OF UROLOGY
    58. Runger, TM; Emmert, S; Schadendorf, D; Diem, C; Epe, B; Hellfritsch, D
      Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    59. Kitada, S; Zapata, JM; Andreeff, M; Reed, JC
      Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia

      BLOOD
    60. Rieger, L; Rieger, J; Winter, S; Streffer, J; Esser, P; Dichgans, J; Meyermann, R; Weller, M
      Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo

      ACTA NEUROPATHOLOGICA
    61. Schneiderman, D; Kim, JM; Senterman, M; Tsang, BK
      Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells

      APOPTOSIS
    62. Giri, DK; Pantazis, P; Aggarwal, BB
      Cellular resistance to vincristine suppresses NF-kappa B activation and apoptosis but enhances c-Jun-NH2-terminal protein kinase activation by tumor necrosis factor

      APOPTOSIS
    63. Esteller, M; Xercavins, J; Reventos, J
      Advances in the molecular genetics of endometrial cancer (Review)

      ONCOLOGY REPORTS
    64. Borner, C; Wadl, HS; Fellay, I; Selzer, E; Polterauer, P; Jansen, B
      Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice

      MELANOMA RESEARCH
    65. Serrone, L; Horsey, P
      The chemoresistance of human malignant melanoma: an update

      MELANOMA RESEARCH
    66. Blandino, G; Levine, AJ; Oren, M
      Mutant p53 gain of function: differential effects of different p53 mutantson resistance of cultured cells to chemotherapy

      ONCOGENE
    67. Periti, P; Mazzei, T
      New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    68. Thomas, M; Rube, C; Semik, M; von Eiff, M; Klinke, F; Macha, HN; Freitag, L; Scheld, HH; Willich, N; Berdel, WE; Junker, K
      Trimodality therapy in stage III non-small cell lung cancer: prediction ofrecurrence by assessment of p185(neu)

      EUROPEAN RESPIRATORY JOURNAL
    69. Nagane, M; Asai, A; Shibui, S; Oyama, H; Nomura, K; Kuchino, Y
      Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    70. Aref, A; Yudelev, M; Mohammad, R; Choudhuri, R; Orton, C; Al-Katib, A
      Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    71. Galimberti, S; Papineschi, F; Carmignani, A; Testi, R; Fazzi, R; Petrini, M
      Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia

      BONE MARROW TRANSPLANTATION
    72. Gauchez, AS; D'Hardemare, AD; Lunardi, J; Vuillez, JP; Fagret, D
      Potential use of radiolabeled antisense oligonucleotides in oncology

      ANTICANCER RESEARCH
    73. Durrieu, F; Belaud-Rotureau, MA; Lacombe, F; Dumain, P; Reiffers, J; Boisseau, MR; Bernard, P; Belloc, F
      Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines

      CYTOMETRY
    74. Sinha, P; Hutter, G; Kottgen, E; Dietel, M; Schadendorf, D; Lage, H
      Increased expression of epidermal fatty acid binding protein, cofilin, and14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas

      ELECTROPHORESIS
    75. Sinha, P; Hutter, G; Kottgen, E; Dietel, M; Schadendorf, D; Lage, H
      Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two-dimensional electrophoresis, mass spectrometry and microsequencing

      ELECTROPHORESIS
    76. Urban, T; Baleyte, T; Chastang, CL; Jeannin, L; Delaval, P; Zaegel, M; Mornet, M; Coetmeur, D; Lebeau, B
      Standard combination versus alternating chemotherapy in small cell lung cancer - A randomised clinical trial including 394 patients

      LUNG CANCER
    77. Konishi, I; Kuroda, H; Mandai, M
      Review: Gonadotropins and development of ovarian cancer

      ONCOLOGY
    78. Yamamoto, M; Tsujinaka, T; Shiozaki, H; Doki, Y; Tamura, S; Inoue, M; Hirao, M; Monden, M
      Metallothionein expression correlates with the pathological response of patients with esophageal cancer undergoing preoperative chemoradiation therapy

      ONCOLOGY
    79. Miyake, H; Hara, I; Yamanaka, L; Arakawa, S; Kamidono, S
      Synergistic enhancement of resistance to cisplatin in human bladder cancercells by overexpression of mutant-type p53 and Bcl-2

      JOURNAL OF UROLOGY
    80. Nguyen, DM; Chen, A; Mixon, A; Schrump, DS
      Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    81. Lopez-Guerrero, JA; Bolufer-Gilabert, P; Vera-Sempere, FJ; de la Concha, IM; Barragan-Gonzalez, E
      C-erbB-2 expression and its relationship with ploidy, p53 abnormalities and epidermal growth factor receptor content in human non-small cell lung cancer

      CLINICA CHIMICA ACTA
    82. Jimenez, RE; Zalupski, MM; Frank, JJ; Du, W; Ryan, JR; Lucas, DR
      Multidrug resistance phenotype in high grade soft tissue sarcoma - Correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy

      CANCER
    83. Kitada, S; Zapata, JM; Andreeff, M; Reed, JC
      Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    84. Dumontet, C; Fabianowska-Majewska, K; Mantincic, D; Bauchu, EC; Tigaud, I; Gandhi, V; Lepoivre, M; Peters, GJ; Rolland, MO; Wyczechowska, D; Fang, X; Gazzo, S; Voorn, DA; Vanier-Viornery, A; Mackey, J
      Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562

      BRITISH JOURNAL OF HAEMATOLOGY
    85. Chang, LC; Sheu, HM; Huang, YS; Tsai, TR; Kuo, KW
      A novel function of emodin - Enhancement of the nucleotide excision repairof UV- and cisplatin-induced DNA damage in human cells

      BIOCHEMICAL PHARMACOLOGY
    86. Periti, P; Mazzei, T
      Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review

      JOURNAL OF CHEMOTHERAPY
    87. MANCINI M; SEDGHINASAB M; KNOWLTON K; TAM A; HOCKENBERY D; ANDERSON BO
      FLOW CYTOMETRIC MEASUREMENT OF MITOCHONDRIAL MASS AND FUNCTION - A NOVEL METHOD FOR ASSESSING CHEMORESISTANCE

      Annals of surgical oncology
    88. PEPPER C; HOY T; BENTLEY P
      ELEVATED BCL-2 BAX ARE A CONSISTENT FEATURE OF APOPTOSIS RESISTANCE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA AND ARE CORRELATED WITH IN-VIVO CHEMORESISTANCE/

      Leukemia & lymphoma
    89. Reed, JC
      Bcl-2 family proteins

      ONCOGENE
    90. MATTII L; BARALE R; PETRINI M
      USE OF THE COMET TEST IN THE EVALUATION OF MULTIDRUG-RESISTANCE OF HUMAN CELL-LINES

      Leukemia
    91. GRUDE P; CONTI F; MOLINIER N; CHAUSSADE S; CALMUS Y
      MECHANISMS OF RESISTANCE TO ANTICANCER DR UGS IN DIGESTIVE CANCERS

      Gastroenterologie clinique et biologique
    92. Goldmann, T; Ribbert, D; Suter, L; Brode, M; Otto, F
      Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    93. BAUMGARTNER G; GOMARHOSS C; SAKR L; ULSPERGER E; WOGRITSCH C
      THE IMPACT OF EXTRACELLULAR-MATRIX ON THE CHEMORESISTANCE OF SOLID TUMORS - EXPERIMENTAL AND CLINICAL-RESULTS OF HYALURONIDASE AS ADDITIVE TO CYTOSTATIC CHEMOTHERAPY

      Cancer letters
    94. ABAD A; MASSUTI B; BLANCO E; CARRATO A; MAUREL J; CERVANTES A; ARANDA E; ANTON A; VICENT JM; DORTA J; DEPAREDES MLG; ARIZA A
      72 HOUR EPIRUBICIN INFUSION PLUS QUINIDINE IN UNRESECTABLE AND METASTATIC ADENOCARCINOMA OF THE PANCREAS - A PHASE-II TRIAL

      American journal of clinical oncology
    95. Boutonnat, J; Muirhead, KA; Barbier, M; Mousseau, M; Ronot, X; Seigneurin, D
      PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines

      ANTICANCER RESEARCH
    96. ELLIS PA; SMITH IE; DETRE S; BURTON SA; SALTER J; AHERN R; WALSH G; JOHNSTON SRD; DOWSETT M
      REDUCED APOPTOSIS AND PROLIFERATION AND INCREASED BCL-2 IN RESIDUAL BREAST-CANCER FOLLOWING PREOPERATIVE CHEMOTHERAPY

      Breast cancer research and treatment
    97. TREPEL M; GROSCURTH P; MALIPIERO U; GULBINS E; DICHGANS J; WELLER M
      CHEMOSENSITIVITY OF HUMAN-MALIGNANT GLIOMA - MODULATION BY P53 GENE-TRANSFER

      Journal of neuro-oncology
    98. Sinha, P; Hutter, G; Kottgen, E; Dietel, M; Schadendorf, D; Lage, H
      Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    99. PEPPER C; THOMAS A; TUCKER H; HOY T; BENTLEY P
      FLOW CYTOMETRIC ASSESSMENT OF 3 DIFFERENT METHODS FOR THE MEASUREMENTOF IN-VITRO APOPTOSIS

      Leukemia research
    100. KLOSTERGAARD J; AUZENNE E; LEROUX E
      CHARACTERIZATION OF CYTOTOXICITY INDUCED BY SPHINGOLIPIDS IN MULTIDRUG-RESISTANT LEUKEMIA-CELLS

      Leukemia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 03:05:03